Migraine Associated Vertigo: Clinical Trials

3 trials for Migraine Associated Vertigo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 41Not yet recruiting 1

Follow Migraine Associated Vertigo: new trials by email Literature Review of Migraine Associated Vertigo trials Research Report on Migraine Associated Vertigo

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Galcanezumab, Erenumab 70 mg, Eptinezumab - Migraine Associated Vertigo, Tinnitus
Phase 4Not yet recruitingStanford University1202026-07-012026-06-17
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
Otoband Experimental, Otoband Sham - Vestibular Migraine, Migraine Associated Vertigo
Not applicableCompletedOtolith Labs3222024-03-062025-01-30
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
Otoband Experimental, Otoband Sham - Vertigo, BPPV
Not applicableCompletedOtolith Labs1092023-02-022025-03-20

Narrower conditions

Benign Paroxysmal Positional Vertigo (1)  ·  Meniere Disease (1)  ·  Migraine Disorders (1)  ·  Tinnitus (1)  ·  Vertigo (1)  ·  Vestibular Diseases (1)

Broader conditions

Ear Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Endolymphatic Hydrops (1)  ·  Headache Disorders (1)  ·  Headache Disorders, Primary (1)  ·  Hearing Disorders (1)  ·  Labyrinth Diseases (1)  ·  Sensation Disorders (1)

Interventions

Amitriptyline (1)  ·  Nortriptyline (1)  ·  Propranolol (1)  ·  Topiramate (1)  ·  Verapamil (1)  ·  atogepant (1)  ·  candesartan (1)  ·  eptinezumab (1)  ·  erenumab (1)  ·  galcanezumab (1)

Sponsors

Otolith Labs (2)  ·  Stanford University (1)

Countries

United States (2)

Top investigators

Didier Depireux, PhD (2)  ·  Kristen K. Steenerson (1)  ·  Matthew Fitzgerald (1)